RANDOMIZED STUDY OF AMPHOTERICIN B INHALATIONFOR THE PROPHYLAXIS OF FUNGAL INFECTIONS(Behre et al. Ann.Hematol. 1995 - Germany)
0 5 10 15 20 25 30 35 40 45 50 55 60%
amphotericin B
aerosol
control
group
proven fungal infections (p > 0.05)
perceived need for
amphotericin B i.v.
mortality at the end
of neutropenia
n = 115
Previous slide
Next slide
Back to first slide
View graphic version